These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31426092)

  • 1. Severe Malaria Treatment in the United States at the Precipice.
    Krey RA; Travassos MA
    Ann Intern Med; 2019 Sep; 171(5):362-363. PubMed ID: 31426092
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanded Availability of Intravenous Artesunate for the Treatment of Severe Malaria in the United States.
    Rosenthal PJ; Tan KR
    Am J Trop Med Hyg; 2019 Jun; 100(6):1295-1296. PubMed ID: 30927931
    [No Abstract]   [Full Text] [Related]  

  • 3. Availability and use of parenteral quinidine gluconate for severe or complicated malaria.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Dec; 49(50):1138-40. PubMed ID: 11190119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the Centers for Disease Control and Prevention. Availability and use of parenteral quinidine gluconate for severe or complicated malaria.
    JAMA; 2001 Feb; 285(6):730. PubMed ID: 11236771
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe
    Shah PJ; Koshy J; Everett N; Attia E
    J Pharm Pract; 2020 Feb; 33(1):108-112. PubMed ID: 29898630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Availability of parenteral quinidine gluconate for treatment of severe or complicated malaria.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jun; 45(23):494-5. PubMed ID: 8628210
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe Malaria.
    Kitabi E; Bensman TJ; Earp JC; Chilukuri DM; Smith H; Ball L; O'Shaughnessy E; Yasinskaya Y; Colangelo PM; Reynolds KS
    Clin Infect Dis; 2021 Sep; 73(5):903-906. PubMed ID: 33605994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of intravenous artesunate treatment for Plasmodium falciparum malaria in a splenectomized traveller: A diagnostic challenge.
    Marco-Hernández J; Camprubí D; Aylagas C; Gupta H; Castro P
    Travel Med Infect Dis; 2019; 30():142-143. PubMed ID: 30227244
    [No Abstract]   [Full Text] [Related]  

  • 9. Blackwater fever in a non-immune patient with Plasmodium falciparum malaria after intravenous artesunate.
    Rodriguez-Valero N; Castro P; Martinez G; Marco Hernandez J; Fernandez S; Gascon J; Nicolas JM
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 29394389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 21-year-old woman from Africa with fever, anemia, and jaundice 7 days after arriving in the US.
    Levins TT
    J Emerg Nurs; 2006 Feb; 32(1):51-3. PubMed ID: 16439288
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of severe Plasmodium falciparum malaria with quinidine gluconate: discontinuation of parenteral quinine from CDC drug service.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Apr; 40(14):240. PubMed ID: 1848916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe imported Falciparum malaria treated with artesunate].
    Danguy des Déserts M; Montelescaut E; Di Costanzo L; Commandeur D; Nguyen BV; Ould-Ahmed M; Taudon N; Drouillard I
    Ann Biol Clin (Paris); 2012; 70(6):733-40. PubMed ID: 23207821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral Artesunate for Severe Imported Plasmodium falciparum Malaria in Children.
    Levy M; Pham LL; Faye A; de Suremain N; Rambaud J; Angoulvant A; Miatello J; Dauger S; Naudin J
    Pediatr Infect Dis J; 2016 Sep; 35(9):1053-4. PubMed ID: 27518753
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous quinidine gluconate and exchange transfusion for malignant Plasmodium falciparum malaria.
    Green G
    Del Med J; 1994 Oct; 66(10):553. PubMed ID: 7958120
    [No Abstract]   [Full Text] [Related]  

  • 15. Trouble from the tropics: challenges in managing malaria in Rhode Island.
    Dworkin J; Janvier M; Treaba D; Gardner A
    R I Med J (2013); 2013 May; 96(5):40-2. PubMed ID: 23641463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food and Drug Administration Approval of Artesunate for Severe Malaria: Enough to Achieve Best Practice?
    Thomas CM; Stauffer WM; Alpern JD
    Clin Infect Dis; 2023 Feb; 76(3):e864-e866. PubMed ID: 36056897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate v. quinine for severe malaria.
    Naidoo P; Saman S
    S Afr Med J; 2013 May; 103(5):274. PubMed ID: 23971104
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular Detection of Residual Parasitemia after Pyronaridine-Artesunate or Artemether-Lumefantrine Treatment of Uncomplicated
    Roth JM; Sawa P; Omweri G; Makio N; Osoti V; de Jong MD; Schallig HDFH; Mens PF
    Am J Trop Med Hyg; 2018 Oct; 99(4):970-977. PubMed ID: 30105967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice.
    Treeprasertsuk S; Silachamroon U; Krudsood S; Huntrup A; Suwannakudt P; Vannaphan S; Wilairatana P
    J Gastroenterol Hepatol; 2010 Feb; 25(2):362-8. PubMed ID: 19817958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria and hereditary elliptocytosis.
    Boctor FN; Dorion RP
    Am J Hematol; 2008 Sep; 83(9):753. PubMed ID: 17696197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.